VYBION INC has a total of 16 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets biotechnology, pharmaceuticals and micro-structure and nano-technology are MEDIKINE INC, CHANGSHA QINCAI BIOTECHNOLOGY CO LTD and CANCER INST.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 4 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | China | 2 | |
#5 | EPO (European Patent Office) | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | Hong Kong | 1 | |
#8 | Taiwan | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Pharmaceuticals | |
#3 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Measuring microorganism processes | |
#4 | Nanostructure applications |
# | Name | Total Patents |
---|---|---|
#1 | Henderson Lee Alan | 9 |
#2 | Amaro Irene Alexandra | 9 |
#3 | Henderson Lee A | 6 |
#4 | Fletcher G Scott | 3 |
#5 | Wheelock Geoffrey | 1 |
#6 | Miller Brian | 1 |
#7 | Noti John D | 1 |
#8 | Fish Wallace R | 1 |
#9 | Irene Alexandra Amaro Ia | 1 |
#10 | Kriksunov Leo B | 1 |
Publication | Filing date | Title |
---|---|---|
CN105531287A | Single chain intrabodies that alter huntingtin mutant degradation | |
EP2480578A2 | Polypeptide modification | |
US2010143364A1 | Chimeric Antibodies, Compositions and Methods for Treating Cocaine-Related Disorders | |
US2006046260A1 | Amplified bioassay |